FGAM
ANIP icon

Financial Gravity Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Financial Gravity Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-460
Closed -$34K – 1379
2019
Q3 		$34K Buy
460
+36
+8% +$2.69K 0.03% 350
2019
Q2 		$35K Sell
424
-347
-45% -$24.7K 0.03% 388
2019
Q1 		$54K Buy
+771
New +$45.4K 0.04% 295

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Financial Gravity Asset Management's ANIP Position: Q4 2019 in Review

Financial Gravity Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2019, closing a stake of 460 shares — an estimated $34K sold.

Financial Gravity Asset Management first reported a position in ANIP in Q1 2019 and held it in 3 quarters. The position peaked at $54K in Q1 2019. 170 funds tracked by Wall St. Rank hold ANIP as of Q4 2019.

  • Financial Gravity Asset Management reported no remaining ANI Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Financial Gravity Asset Management sold 460 ANI Pharmaceuticals shares in Q4 2019, an estimated $34K.
  • Financial Gravity Asset Management first reported a position in ANI Pharmaceuticals in Q1 2019 and held it in 3 quarters.
  • Financial Gravity Asset Management's ANI Pharmaceuticals position peaked at $54K in Q1 2019.
  • 170 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.